CASI Pharmaceuticals (CASIF) Receivables (2021 - 2025)
CASI Pharmaceuticals (CASIF) recorded Receivables of $4.87 million in Q4 2025, down 69.8% from $16.12 million a year earlier but up 86.7% from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Receivables (2021 - 2025) Analysis & Trends
Starting with Q4 2021, CASI Pharmaceuticals' Receivables history includes 14 quarters.
- Annual Receivables has a four-year compound annual growth rate of -17.6% (FY2021 to FY2025).
- Across earlier years, Receivables came in at $16.12 million in FY2024 (+59.0%), $10.14 million in FY2023 (-26.3%), $13.75 million in FY2022 (+30.0%) and $10.58 million in FY2021.
- Quarterly Receivables has ranged from $2.61 million in Q3 2025 to $16.12 million in Q4 2024 over the past five years.
- On a year-over-year basis, Receivables has declined for three consecutive quarters, with an average decline of 22.6% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 59.0% in Q4 2024, against a decline of 76.6% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.61 million (Q3 2025), $5.36 million (Q2 2025) and $7.6 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | CASI Pharmaceuticals | 2.06 Mn | -18.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.87 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 16.12 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 7.74 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 10.14 Mn |
| Sep 30, 2023 | 11.66 Mn |
| Jun 30, 2023 | 12.53 Mn |
| Mar 31, 2023 | 11.11 Mn |
| Dec 31, 2022 | 13.75 Mn |
| Dec 31, 2021 | 10.58 Mn |
API Access
CASI Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();